Previous close | 418.82 |
Open | 419.00 |
Bid | 419.00 x 100 |
Ask | 419.48 x 100 |
Day's range | 416.03 - 421.18 |
52-week range | 320.01 - 448.40 |
Volume | |
Avg. volume | 1,042,100 |
Market cap | 108.122B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 27.17 |
EPS (TTM) | 15.42 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 466.90 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.